Home
Alkermes ALKS paid Penn Avenue Partners $80K for lobbying in Q3 2025 · Pharmacy
Trade details
- Type
- Lobbying report
- Amount
- $80,000
- Quarter
- Q3 2025
- Stock
- Alkermes ALKS
- Client
- Alkermes
- Reported
- 25/10/03
Up 14.3% from last quarter
What else happened in Alkermes around then
Filed or reported within 30 days of the trade day · 25/08/31~25/10/30Alkermes's other lobbying reports
- Alkermes
LobbyingAlkermes
LobbyingAlkermes
ALKS
Under $5,000
Under $5,000
Reported 09/15
for Q2
- Alkermes
LobbyingAlkermes
LobbyingAlkermes
ALKS
$60K
$60K
Reported 08/03
for Q2
- Alkermes
LobbyingAlkermes
LobbyingAlkermes
ALKS
$60K
$60K
Reported 07/20
for Q2
- Alkermes
LobbyingAlkermes
LobbyingAlkermes
ALKS
$50K
$50K
Reported 07/20
for Q2
- Alkermes
LobbyingAlkermes
LobbyingAlkermes
ALKS
$930K
$930K
Reported 07/20
for Q2